论文部分内容阅读
目的探讨同型半胱氨酸与高血压和高血压合并脑卒中的关系。方法测定107例高血压患者、38例高血压合并脑卒中患者和101例健康人血浆同型半胱氨酸水平。结果高血压合并脑卒中患者血浆同型半胱氨酸水平(24.1±4.6)>高血压患者血浆同型半胱氨酸水平(19.3±3.7)>健康人血浆同型半胱氨酸水平(8.95±1.43)。结论同型半胱氨酸是高血压发生的重要因素,而高同型半胱氨酸又是高血压患者发生脑卒中的危险因素。
Objective To investigate the relationship between homocysteine and hypertension and hypertension complicated with stroke. Methods Plasma homocysteine level was measured in 107 hypertensive patients, 38 hypertensive patients with stroke and 101 healthy subjects. Results The levels of plasma homocysteine (24.1 ± 4.6) and plasma homocysteine (19.3 ± 3.7) in patients with hypertension and stroke were significantly higher than those in healthy subjects (8.95 ± 1.43) . Conclusion Homocysteine is an important factor in the development of hypertension, and homocysteine is also a risk factor for stroke in hypertensive patients.